These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2465527)

  • 1. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
    Potts WM; Reynolds AB; Lansing TJ; Parsons JT
    Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
    Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
    Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
    Kanner SB; Parsons SJ; Parsons JT; Gilmer TM
    Oncogene; 1988 Apr; 2(4):327-35. PubMed ID: 2452399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of carboxyl terminal truncation and point mutations on pp60c-src activities.
    Yaciuk P; Cannella MT; Shalloway D
    Oncogene Res; 1988 Sep; 3(2):207-12. PubMed ID: 2465526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amino-terminal half of pp59c-fyn contains sequences necessary for formation of a 75 kDa form and also repressive elements absent in pp60c-src.
    Espino PC; Chou WY; Smith AE; Cheng SH
    Oncogene; 1992 Feb; 7(2):317-22. PubMed ID: 1372400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From c-src to v-src, or the case of the missing C terminus.
    Sefton BM; Hunter T
    Cancer Surv; 1986; 5(2):159-72. PubMed ID: 2430701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase.
    Zheng XM; Wang Y; Pallen CJ
    Nature; 1992 Sep; 359(6393):336-9. PubMed ID: 1383828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and phorbol ester induce distinct phosphorylations of pp60c-src in the BC3H-1 murine myocyte cell line.
    Luttrell LM; Luttrell DK; Parsons SJ; Rogol AD
    Oncogene; 1989 Mar; 4(3):317-24. PubMed ID: 2468125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain.
    Liu X; Brodeur SR; Gish G; Songyang Z; Cantley LC; Laudano AP; Pawson T
    Oncogene; 1993 May; 8(5):1119-26. PubMed ID: 7683128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mutant forms of the c-src gene product containing a phenylalanine substitution for tyrosine 416.
    Ferracini R; Brugge J
    Oncogene Res; 1990; 5(3):205-19. PubMed ID: 1690870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo phosphorylation states and kinase activities of transforming p60c-src mutants.
    Jove R; Hanafusa T; Hamaguchi M; Hanafusa H
    Oncogene Res; 1989; 5(1):49-60. PubMed ID: 2476707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myristylation and amino-terminal phosphorylation are required for activation of pp60c-src during mitosis.
    Kaech S; Schnierle B; Wyss A; Ballmer-Hofer K
    Oncogene; 1993 Mar; 8(3):575-81. PubMed ID: 7679790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphorylation of a 120,000 dalton membrane-associated protein by the neural form of pp60c-src, pp60c-src+.
    Flynn DC; Schaller MD; Parsons JT
    Oncogene; 1992 Mar; 7(3):579-83. PubMed ID: 1372401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avian pp60c-src is more active when expressed in yeast than in vertebrate fibroblasts.
    Cooper JA; Runge K
    Oncogene Res; 1987; 1(4):297-310. PubMed ID: 2453017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidic residues at the carboxyl terminus of p60c-src are required for regulation of tyrosine kinase activity and transformation.
    MacAuley A; Cooper JA
    New Biol; 1990 Sep; 2(9):828-40. PubMed ID: 1703788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of pp60c-src tyrosine kinase activity during secretion in stimulated bovine adrenal chromaffin cells.
    Oddie KM; Litz JS; Balserak JC; Payne DM; Creutz CE; Parsons SJ
    J Neurosci Res; 1989 Sep; 24(1):38-48. PubMed ID: 2478720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.